Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting neurological disorders. Shows potential in the development of central nervous system agents due to its structural affinity with dopamine and serotonin receptor ligands. Investigated for use in treatments of depression, anxiety, and neurodegenerative diseases. Also employed in the creation of novel analgesics with reduced side effect profiles. Its rigid polycyclic framework makes it valuable in structure-activity relationship studies for optimizing drug candidates.